Federated Hermes Us Strategic Dividend Etf logo

Federated Hermes Us Strategic Dividend Etf (FDV) Technical Analysis

$28.490.78%

Insights

  • Federated Hermes Us Strategic Dividend Etf is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Federated Hermes Us Strategic Dividend Etf stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Federated Hermes Us Strategic Dividend Etf stock is Range bound.
  • Based on analysis of the Pivot Points, the current market trend for Federated Hermes Us Strategic Dividend Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
49.36
Neutral
Stochastic
25.55, 42.21
Neutral
Ultimate Oscillator
36.17
Neutral
Stochastic Relative Strength Index
36.03, 29.73
Neutral
Moving Average Convergence Divergence
0.05, 0.09
Sell

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
28.5
Sell
20
28.56
Buy
50
28.35
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
28.5
Buy
20
28.48
Buy
50
28.25
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
28.54
Neutral
20
28.59
Neutral
50
28.34
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
28.48
Sell
20
28.57
Sell
50
28.72
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
28.44
Sell
20
28.5
Sell
50
28.67
Sell

Pivot

Pivot

Value

Resistance L3
29.34
Resistance L2
29.18
Resistance L1
28.84
Pivot Point
28.68
Support L1
28.34
Support L2
28.18
Support L3
27.84

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.